Revatio is Food and Drug Administration (FDA)–approved to treat pulmonary arterial hypertension (PAH). PAH is a condition ...

Sildenafil is the generic equivalent of Pfizer’s Revatio, which is indicated for the treatment of pulmonary arterial hypertension in adults, to improve exercise ability and delay clinical worsening.

Pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and delay clinical worsening, in adults who are temporarily unable to take oral Revatio. Give by IV bolus injection.

An attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a new paediatric indication has had a major setback. Revatio (sildenafil citrate ...